Amy R. Perwien

2.2k total citations
26 papers, 1.6k citations indexed

About

Amy R. Perwien is a scholar working on Clinical Psychology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Amy R. Perwien has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Clinical Psychology, 18 papers in Psychiatry and Mental health and 4 papers in Cognitive Neuroscience. Recurrent topics in Amy R. Perwien's work include Child and Adolescent Psychosocial and Emotional Development (19 papers), Attention Deficit Hyperactivity Disorder (18 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). Amy R. Perwien is often cited by papers focused on Child and Adolescent Psychosocial and Emotional Development (19 papers), Attention Deficit Hyperactivity Disorder (18 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). Amy R. Perwien collaborates with scholars based in United States, Japan and Switzerland. Amy R. Perwien's co-authors include Gail A. Bernstein, CARRIE M. BORCHARDT, Regina Bussing, Ross D. Crosby, Nancy E. Schoenberg, Ralph Swindle, Bonnie T. Zima, Paul Thuras, Douglas E. Faries and Christopher J. Kratochvil and has published in prestigious journals such as American Journal of Public Health, Social Science & Medicine and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Amy R. Perwien

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy R. Perwien United States	20	1.0k	928	338	286	281	26	1.6k
Theodore A. Petti United States	23	1.2k 1.2×	587 0.6×	253 0.7×	142 0.5×	132 0.5×	76	1.9k
W. Burleson Daviss United States	19	1.2k 1.1×	856 0.9×	308 0.9×	89 0.3×	118 0.4×	29	1.8k
Paula Riggs United States	27	1.3k 1.2×	855 0.9×	239 0.7×	129 0.5×	71 0.3×	53	2.2k
Peter Marton Canada	23	1.0k 1.0×	427 0.5×	135 0.4×	134 0.5×	163 0.6×	47	1.5k
Joseph Woolston United States	18	903 0.9×	420 0.5×	219 0.6×	144 0.5×	103 0.4×	54	1.2k
Bruce Waslick United States	16	1.9k 1.8×	737 0.8×	286 0.8×	385 1.3×	105 0.4×	26	2.4k
H. Bruce Ferguson Canada	13	505 0.5×	476 0.5×	145 0.4×	114 0.4×	176 0.6×	26	944
Caroly Pataki United States	16	797 0.8×	795 0.9×	254 0.8×	63 0.2×	111 0.4×	37	1.5k
Melissa Mulraney Australia	21	536 0.5×	702 0.8×	295 0.9×	108 0.4×	132 0.5×	58	1.2k
L. Eugene Arnold United States	23	1.1k 1.0×	1.7k 1.8×	1.2k 3.5×	172 0.6×	484 1.7×	66	2.4k

Countries citing papers authored by Amy R. Perwien

Since Specialization

Citations

This map shows the geographic impact of Amy R. Perwien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy R. Perwien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy R. Perwien more than expected).

Fields of papers citing papers by Amy R. Perwien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy R. Perwien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy R. Perwien. The network helps show where Amy R. Perwien may publish in the future.

Co-authorship network of co-authors of Amy R. Perwien

This figure shows the co-authorship network connecting the top 25 collaborators of Amy R. Perwien. A scholar is included among the top collaborators of Amy R. Perwien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy R. Perwien. Amy R. Perwien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kratochvil, Christopher J., Douglas E. Faries, Brigette S. Vaughan, et al.. (2007). Emotional Expression During Attention-Deficit/Hyperactivity Disorders Treatment: Initial Assessment of Treatment Effects. Journal of Child and Adolescent Psychopharmacology. 17(1). 51–62. 21 indexed citations

Perwien, Amy R., Christopher J. Kratochvil, Douglas E. Faries, et al.. (2007). Emotional Expression in Children Treated With ADHD Medication. Journal of Attention Disorders. 11(5). 568–579. 22 indexed citations

Perwien, Amy R., Christopher J. Kratochvil, Douglas E. Faries, et al.. (2006). Atomoxetine Treatment in Children and Adolescents with Attention-Deficit Hyperactivity Disorder: What Are the Long-Term Health-Related Quality-of-Life Outcomes?. Journal of Child and Adolescent Psychopharmacology. 16(6). 713–724. 56 indexed citations

Whalen, Carol K., Barbara Henker, Larry D. Jamner, et al.. (2006). Toward Mapping Daily Challenges of Living with ADHD: Maternal and Child Perspectives Using Electronic Diaries. Journal of Abnormal Child Psychology. 34(1). 111–126. 96 indexed citations

Brown, Ronald T., Amy R. Perwien, Douglas E. Faries, Christopher J. Kratochvil, & Brigette S. Vaughan. (2006). Atomoxetine in the Management of Children with ADHD: Effects on Quality of Life and School Functioning. Clinical Pediatrics. 45(9). 819–827. 44 indexed citations

Brod, Meryl, Amy R. Perwien, Lenard A. Adler, Thomas Spencer, & Joseph A. Johnston. (2005). Conceptualization and Assessment of Quality of Life for Adults with Attention- Deficit/Hyperactivity Disorder. 12(6). 58–64. 56 indexed citations

Perwien, Amy R., et al.. (2005). A Comparison of Service Use and Costs Among Adults With ADHD and Adults With Other Chronic Diseases. Psychiatric Services. 56(12). 1593–1599. 20 indexed citations

Perwien, Amy R., Jennifer Hall, Andrine R. Swensen, & Ralph Swindle. (2004). Stimulant Treatment Patterns and Compliance in Children and Adults With Newly Treated Attention-Deficit/Hyperactivity Disorder. Journal of Managed Care Pharmacy. 10(2). 122–129. 117 indexed citations

Perwien, Amy R., Douglas E. Faries, Christopher J. Kratochvil, et al.. (2004). Improvement in Health-Related Quality of Life in Children with ADHD. Journal of Developmental & Behavioral Pediatrics. 25(4). 264–271. 72 indexed citations

10.

Stockl, Karen M., et al.. (2003). Physician Perceptions of the Use of Medications for Attention Deficit Hyperactivity Disorder. Journal of Managed Care Pharmacy. 9(5). 416–423. 43 indexed citations

11.

Stockl, Karen M., et al.. (2003). PNP4: PHYSICIAN PERCEPTIONS ON THE USE OF MEDICATIONS FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER. Value in Health. 6(3). 272–272. 1 indexed citations

12.

Bussing, Regina, Bonnie T. Zima, & Amy R. Perwien. (2000). Self-Esteem in Special Education Children With ADHD: Relationship to Disorder Characteristics and Medication Use. Journal of the American Academy of Child & Adolescent Psychiatry. 39(10). 1260–1269. 59 indexed citations

13.

Bernstein, Gail A., CARRIE M. BORCHARDT, Amy R. Perwien, et al.. (2000). Imipramine Plus Cognitive-Behavioral Therapy in the Treatment of School Refusal. Journal of the American Academy of Child & Adolescent Psychiatry. 39(3). 276–283. 133 indexed citations

14.

Bussing, Regina, Bonnie T. Zima, Amy R. Perwien, Thomas R. Belin, & Mel H. Widawski. (1998). Children in special education programs: attention deficit hyperactivity disorder, use of services, and unmet needs.. American Journal of Public Health. 88(6). 880–886. 115 indexed citations

15.

Bussing, Regina, Elena M. Schuhmann, Thomas R. Belin, Mel H. Widawski, & Amy R. Perwien. (1998). Diagnostic Utility of Two Commonly Used ADHD Screening Measures Among Special Education Students. Journal of the American Academy of Child & Adolescent Psychiatry. 37(1). 74–82. 42 indexed citations

16.

Bernstein, Gail A., et al.. (1998). Caffeine Withdrawal in Normal School-Age Children. Journal of the American Academy of Child & Adolescent Psychiatry. 37(8). 858–865. 50 indexed citations

17.

Bernstein, Gail A., et al.. (1997). Somatic Symptoms in Anxious-Depressed School Refusers. Journal of the American Academy of Child & Adolescent Psychiatry. 36(5). 661–668. 113 indexed citations

18.

Bernstein, Gail A., CARRIE M. BORCHARDT, & Amy R. Perwien. (1996). Anxiety Disorders in Children and Adolescents: A Review of the Past 10 Years. Journal of the American Academy of Child & Adolescent Psychiatry. 35(9). 1110–1119. 263 indexed citations

19.

Bernstein, Gail A., et al.. (1996). Management of Blood-Drawing Fears in Adolescents with Comorbid Anxiety and Depressive Disorders. Journal of Child and Adolescent Psychopharmacology. 6(1). 53–61. 3 indexed citations

20.

Bernstein, Gail A., et al.. (1994). Caffeine Effects on Learning, Performance, and Anxiety in Normal School-Age Children. Journal of the American Academy of Child & Adolescent Psychiatry. 33(3). 407–415. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact